AlzeCure Pharma AB (publ) AC6.F Stock
AlzeCure Pharma AB (publ) Price Chart
AlzeCure Pharma AB (publ) AC6.F Financial and Trading Overview
| AlzeCure Pharma AB (publ) stock price | 0.15 EUR |
| Previous Close | 0.49 EUR |
| Open | 0.49 EUR |
| Bid | 0.5 EUR x 0 |
| Ask | 0.55 EUR x 0 |
| Day's Range | 0.49 - 0.49 EUR |
| 52 Week Range | 0.18 - 0.52 EUR |
| Volume | 1K EUR |
| Avg. Volume | 464 EUR |
| Market Cap | 30.55M EUR |
| Beta (5Y Monthly) | 0.699672 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.05 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
AC6.F Valuation Measures
| Enterprise Value | 32.41M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
AlzeCure Pharma AB (publ) Stock Price History
| Beta (5Y Monthly) | 0.699672 |
| 52-Week Change | 134.08% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.52 EUR |
| 52 Week Low | 0.18 EUR |
| 50-Day Moving Average | 0.39 EUR |
| 200-Day Moving Average | 0.37 EUR |
AC6.F Share Statistics
| Avg. Volume (3 month) | 464 EUR |
| Avg. Daily Volume (10-Days) | 2.6K EUR |
| Shares Outstanding | 62.09M |
| Float | 44.83M |
| Short Ratio | N/A |
| % Held by Insiders | 41.31% |
| % Held by Institutions | 6.48% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -50.23% |
| Return on Equity (ttm) | -94.34% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.09 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 8.179 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of AlzeCure Pharma AB (publ)
| Country | Germany |
| State | N/A |
| City | Huddinge |
| Address | Hälsovägen 7 |
| ZIP | 141 57 |
| Phone | 46 7 63 16 24 77 |
| Website | https://www.alzecurepharma.se |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 12 |
AlzeCure Pharma AB (publ), a pharmaceutical company, develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is developing drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms. Its pipeline products include ACD856, which is in phase I clinical trial to treat Alzheimer's disease, sleep disorders, traumatic brain injuries, and Parkinson's disease; ACD857, ACD679, and ACD680 that are in preclinical trial for the treatment of Alzheimer's disease; ACD440, a TRPV1 antagonist that has completed phase I clinical trial for neuropathic pain; and TrkA-NAM for osteoarthritic pain. The company was founded in 2012 and is based in Huddinge, Sweden.
Q&A For AlzeCure Pharma AB (publ) Stock
What is a current AC6.F stock price?
AlzeCure Pharma AB (publ) AC6.F stock price today per share is 0.15 EUR.
How to purchase AlzeCure Pharma AB (publ) stock?
You can buy AC6.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for AlzeCure Pharma AB (publ)?
The stock symbol or ticker of AlzeCure Pharma AB (publ) is AC6.F.
Which industry does the AlzeCure Pharma AB (publ) company belong to?
The AlzeCure Pharma AB (publ) industry is Drug Manufacturers-Specialty & Generic.
How many shares does AlzeCure Pharma AB (publ) have in circulation?
The max supply of AlzeCure Pharma AB (publ) shares is 93.34M.
What is AlzeCure Pharma AB (publ) Price to Earnings Ratio (PE Ratio)?
AlzeCure Pharma AB (publ) PE Ratio is now.
What was AlzeCure Pharma AB (publ) earnings per share over the trailing 12 months (TTM)?
AlzeCure Pharma AB (publ) EPS is -0.05 EUR over the trailing 12 months.
Which sector does the AlzeCure Pharma AB (publ) company belong to?
The AlzeCure Pharma AB (publ) sector is Healthcare.